Real Estate Archives - Page 6 of 26 - Boston Life Sciences Times

Revvity, Lilly Partner to Broaden Biotech Access to AI Drug Discovery Models

January 9, 2026

How Industry Trends are Impacting Hiring Decisions and Leadership Strategies in Life Sciences

January 6, 2026

Foray Bioscience Secures First Fabricated Seed Partnership With West Coast Chestnut

January 5, 2026

THIS WEEK'S STORIES

Ascidian Therapeutics and Forge Biologics Partner to Advance RNA Editing Therapy for Stargardt Disease

January 7, 2026

Nia Therapeutics Validates 60-Channel Brain Implant for Closed-Loop Neurostimulation in Peer-Reviewed Study

January 5, 2026

Ventus Therapeutics Names VENT-04 as Development Candidate for Inflammatory Diseases

January 7, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Real Estate

BioMed Realty Highlights Sustainability Progress and GRESB Recognition in 2024 Report

Suffolk hires Roger Moore to strengthen healthcare construction leadership in California

Curium Pharma Selects Boston Seaport for New Global Headquarters

Instem Opens New Global Headquarters in Boston

Labshares Opens New Watertown Site, Doubles Its Footprint and Extends Shared-Lab Access to More Biotech Firms

Most Read

Aurora Therapeutics Launches With $16 Million Seed Round to Scale Personalized Gene Editing for Rare Diseases

GC Therapeutics Names Kate Haviland Board Chair, Advances Cell Therapy Pipeline and Platform

MEDIPOST Secures $140 Million to Advance U.S. Phase III Stem Cell Trial

Prolytix Expands Thrombosis and Hemostasis Testing Capabilities With HRL Assay Acquisition

EDITOR PICKS